ATE466879T1 - 5t4-antigen-peptidepitope der mhc klasse ii - Google Patents
5t4-antigen-peptidepitope der mhc klasse iiInfo
- Publication number
- ATE466879T1 ATE466879T1 AT03739570T AT03739570T ATE466879T1 AT E466879 T1 ATE466879 T1 AT E466879T1 AT 03739570 T AT03739570 T AT 03739570T AT 03739570 T AT03739570 T AT 03739570T AT E466879 T1 ATE466879 T1 AT E466879T1
- Authority
- AT
- Austria
- Prior art keywords
- mhc class
- antigen peptide
- peptide epitopes
- epitope
- peptide
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102000043131 MHC class II family Human genes 0.000 abstract 1
- 108091054438 MHC class II family Proteins 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0203420.5A GB0203420D0 (en) | 2002-02-13 | 2002-02-13 | Peptide |
PCT/GB2003/000618 WO2003068815A2 (en) | 2002-02-13 | 2003-02-13 | Mhc class ii peptide epitope of 5t4 antigen |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE466879T1 true ATE466879T1 (de) | 2010-05-15 |
Family
ID=9931005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03739570T ATE466879T1 (de) | 2002-02-13 | 2003-02-13 | 5t4-antigen-peptidepitope der mhc klasse ii |
Country Status (7)
Country | Link |
---|---|
US (2) | US7910109B2 (de) |
EP (1) | EP1474446B1 (de) |
AT (1) | ATE466879T1 (de) |
AU (1) | AU2003245781A1 (de) |
DE (1) | DE60332425D1 (de) |
GB (1) | GB0203420D0 (de) |
WO (1) | WO2003068815A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2277918B1 (de) * | 2005-05-13 | 2012-11-14 | Oxford BioMedica (UK) Limited | Vom Tumorantigen 5t4 abgeleitete Mhc-Klasse-I- und II-Peptidantigene |
GB0520067D0 (en) * | 2005-10-01 | 2005-11-09 | Cancer Rec Tech Ltd | Treatment of cancer |
EP2313784B1 (de) | 2008-07-15 | 2015-02-18 | Oxford BioMedica (UK) Limited | Immuntherapieverfahren |
US9290541B2 (en) | 2011-11-18 | 2016-03-22 | Board Of Regents, The University Of Texas System | TCL1 peptides for immunotherapy |
GB201607535D0 (en) * | 2016-04-29 | 2016-06-15 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
GB201520550D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
GB201520568D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd | Peptides |
SG11201804648RA (en) | 2015-12-04 | 2018-06-28 | Univ Texas | Slc45a2 peptides for immunotherapy |
SG11201903008YA (en) | 2016-10-07 | 2019-05-30 | Univ Texas | Hla-restricted vgll1 peptides and use thereof |
CN110637028A (zh) * | 2016-12-29 | 2019-12-31 | 得克萨斯州大学系统董事会 | Hla限制性vcx/y肽和t细胞受体及其用途 |
US11919937B2 (en) | 2018-01-09 | 2024-03-05 | Board Of Regents, The University Of Texas System | T cell receptors for immunotherapy |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1984002077A1 (en) | 1982-11-30 | 1984-06-07 | Us Health | Process for producing poxvirus recombinants for expression of foreign genes |
GB8305967D0 (en) | 1983-03-04 | 1983-04-07 | Univ Liverpool | Material for treatment of spontaneous abortions |
GB8508845D0 (en) | 1985-04-04 | 1985-05-09 | Hoffmann La Roche | Vaccinia dna |
WO1989007947A1 (en) | 1988-03-04 | 1989-09-08 | Cancer Research Campaign Technology Limited | Improvements relating to antigens |
US5869053A (en) | 1988-03-04 | 1999-02-09 | Cancer Research Campaign Technology, Ltd. | 5T4 antigen from human trophoblasts |
US5118672A (en) | 1989-07-10 | 1992-06-02 | University Of Georgia Research Foundation | 5'-diphosphohexose nucleoside pharmaceutical compositions |
IL92629A0 (en) | 1989-12-10 | 1990-08-31 | Yeda Res & Dev | Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases |
WO2001000225A1 (en) | 1999-06-29 | 2001-01-04 | Epimmune Inc. | Hla binding peptides and their uses |
GB9523703D0 (en) | 1995-11-20 | 1996-01-24 | Wellcome Found | Enzyme prodrug thearapy |
US5864003A (en) | 1996-07-23 | 1999-01-26 | Georgia-Pacific Resins, Inc. | Thermosetting phenolic resin composition |
GB9720465D0 (en) | 1997-09-25 | 1997-11-26 | Oxford Biomedica Ltd | Dual-virus vectors |
NZ503318A (en) | 1997-09-23 | 2001-11-30 | Oxford Biomedica Ltd | Modified haemopoietic stem cell comprised of a spliced upstream with a nucleotide sequence of interest to be used as in gene therapy |
GB2370572B (en) | 1998-11-18 | 2003-05-07 | Oxford Biomedica Ltd | Use of a professional antigen presenting cell |
KR20010084935A (ko) * | 1998-11-18 | 2001-09-07 | 찰스 굿맨 | 폴리펩티드 |
-
2002
- 2002-02-13 GB GBGB0203420.5A patent/GB0203420D0/en not_active Ceased
-
2003
- 2003-02-13 WO PCT/GB2003/000618 patent/WO2003068815A2/en not_active Application Discontinuation
- 2003-02-13 AT AT03739570T patent/ATE466879T1/de not_active IP Right Cessation
- 2003-02-13 US US10/504,603 patent/US7910109B2/en not_active Expired - Fee Related
- 2003-02-13 EP EP03739570A patent/EP1474446B1/de not_active Expired - Lifetime
- 2003-02-13 DE DE60332425T patent/DE60332425D1/de not_active Expired - Lifetime
- 2003-02-13 AU AU2003245781A patent/AU2003245781A1/en not_active Abandoned
-
2011
- 2011-01-31 US US13/017,885 patent/US20130217116A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
GB0203420D0 (en) | 2002-04-03 |
AU2003245781A8 (en) | 2003-09-04 |
US7910109B2 (en) | 2011-03-22 |
EP1474446B1 (de) | 2010-05-05 |
EP1474446A2 (de) | 2004-11-10 |
WO2003068815A2 (en) | 2003-08-21 |
US20050118597A1 (en) | 2005-06-02 |
WO2003068815A3 (en) | 2003-09-18 |
DE60332425D1 (de) | 2010-06-17 |
AU2003245781A1 (en) | 2003-09-04 |
US20130217116A1 (en) | 2013-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200602071A (en) | Methods for preventing and treating alzheimer's disease (ad) | |
ATE376559T1 (de) | Methoden der verhinderung und behandlung der alzheimer'schen krankheit | |
NO20045021L (no) | Immunologiske metoder og preparater for behandling av Alzheimers sykdom | |
NO20022531L (no) | Vaksine for forebyggelse og behandling av Alzheimer- og amyloidrelaterte sykdommer | |
NZ618391A (en) | Antigenic tau peptides and uses thereof | |
AU2002302255A1 (en) | Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases | |
DE69526339D1 (de) | Monoklonale antikörper, die an den vorläufer des tumorabstossantigen mage-1 anbinden, rekombinantes mage-1, und von mage-1 abgebieteteimmunogene peptide | |
RU2008120299A (ru) | СПОСОБЫ ПОЛУЧЕНИЯ КОМПОЗИЦИЙ, ВКЛЮЧАЮЩИХ ХИТШОКОВЫЕ БЕЛКИ ИЛИ α-2-МАКРОГЛОБУЛИН, ПРИГОДНЫХ ДЛЯ ЛЕЧЕНИЯ ЗЛОКАЧЕСТВЕННОЙ ОПУХОЛИ И ИНФЕКЦИОННОГО ЗАБОЛЕВАНИЯ | |
ATE466879T1 (de) | 5t4-antigen-peptidepitope der mhc klasse ii | |
PT1409692E (pt) | Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina | |
ATE360642T1 (de) | Mhc klasse i peptidepitope des humanen tumorassoziierten antigens 5t4 | |
DE60035523D1 (de) | Optimierte minigene und dadurch kodierte peptide | |
NZ592340A (en) | A method for making a virus vaccine compising Replikin peptides | |
DE602004028266D1 (de) | Angiogene peptide und ihre verwendungen | |
PT1417222E (pt) | Polipéptidos isolados baseados no epítopo neutralizante da proteína p17 de vih, úteis como vacinas, e anticorpos antip17 neutralizantes que reconhecem especificamente o referido polipéptido neutralizante | |
DE60127113D1 (de) | Gd3 mimetische peptide | |
DK1778271T3 (da) | Peptid til behandling af herpesvirusinfektioner | |
UA83989C2 (ru) | Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение | |
CO5280140A1 (es) | Antigeno (c42) asociado a tumores | |
EP1557466A4 (de) | Tumorantigenprotein und dessen verwendung | |
DE60015559D1 (de) | Sentrin-spezifische menschliche protease senp1 | |
WO2003064446A3 (en) | Plasma protein-binding peptides from bacterial curli | |
DE602004019141D1 (de) | Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonin (ivtntt) enthaltende biologisch wirksame peptide | |
FR2856598A1 (fr) | Peptides derives de la proteine mmp-2 et leur utilisation en immunotherapie antitumorale | |
DE60223232D1 (de) | Mucinpeptid mit immunstärkenden eigenschaften |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |